Beck, Katherine http://orcid.org/0000-0003-2769-8237
Arumuham, Atheeshaan
Veronese, Mattia http://orcid.org/0000-0003-3562-0683
Santangelo, Barbara
McGinnity, Colm J.
Dunn, Joel http://orcid.org/0000-0002-0936-9993
McCutcheon, Robert A. http://orcid.org/0000-0003-1102-2566
Kaar, Stephen J.
Singh, Nisha
Pillinger, Toby http://orcid.org/0000-0002-6074-2626
Borgan, Faith http://orcid.org/0000-0002-5017-5226
Stone, James http://orcid.org/0000-0003-3051-0135
Jauhar, Sameer http://orcid.org/0000-0002-3878-3659
Sementa, Teresa
Turkheimer, Federico http://orcid.org/0000-0002-3766-3815
Hammers, Alexander
Howes, Oliver D.
Funding for this research was provided by:
Royal College of Psychiatrists
Rosetrees Trust
Stoneygate Trust
DH | National Institute for Health Research
Wellcome Trust (215747/Z/19/Z, WT 203148/Z/16/Z, WT 203148/Z/16/Z, 094849/Z/10/Z)
RCUK | Medical Research Council (MR/N013042/1, MR/K022733/1, MR/K022733/1, MC_MC_A656_5QD30_2135)
Maudsley Charity (66)
King’s College London
Brain and Behavior Research Foundation
DH | NIHR | Health Services Research Programme
Article History
Received: 27 May 2021
Revised: 3 June 2021
Accepted: 28 June 2021
First Online: 12 August 2021
Competing interests
: KB, AA, BS, JD, NS, TS and FT declare no competing interests. MV has received consulting honoraria from GSK. CJM has received fees from GE Healthcare Ltd but neither he nor any of his family have ever been employed by the organisation; nor does he or any of his family have holdings/a financial stake in GE Healthcare Ltd. SK received travel expenses for a scientific meeting from Autifony Ltd. RM has received honoraria for lectures from Otsuka and is an investigator on research funded by Neurocrine.TP has received honoraria for lectures from Lundbeck, Otsuka, and Sunovion. In the last 3 years, JMS has been PI on research studies sponsored by Takeda and Protexin. He has received an honorarium from Janssen for attending an advisory board meeting. SJ has received honoraria for educational talks given for Sunovian. KCL has received honoraria for educational talks SJ has given for Lundbeck. SJ is Co PI on a drug trial for Alkermes. FB became an employee at COMPASS Pathways plc after completion of this work. This work is unrelated to COMPASS Pathways plc. AH has received honoraria or consultation fees from Imperial Innovations and is a shareholder in Imperial Innovations. ODH is a part-time employee of H Lundbeck A/s (obtained post after completion of this project) and has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Jansenn, Lundbeck, Neurocrine, Otsuka, Sunovion, Rand, Recordati, Roche and Viatris/Mylan. Neither Dr Howes or his family have holdings/a financial stake in any pharmaceutical company. Dr Howes has a patent for the use of dopaminergic imaging.